Does BOTULINUM TOXIN TYPE A Cause Osteoarthritis? 427 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 427 reports of Osteoarthritis have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 11.4% of all adverse event reports for BOTULINUM TOXIN TYPE A.
427
Reports of Osteoarthritis with BOTULINUM TOXIN TYPE A
11.4%
of all BOTULINUM TOXIN TYPE A reports
426
Deaths
349
Hospitalizations
How Dangerous Is Osteoarthritis From BOTULINUM TOXIN TYPE A?
Of the 427 reports, 426 (99.8%) resulted in death, 349 (81.7%) required hospitalization, and 359 (84.1%) were considered life-threatening.
Is Osteoarthritis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 427 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Osteoarthritis?
ADALIMUMAB (8,893)
METHOTREXATE (4,979)
ETANERCEPT (4,124)
ABATACEPT (3,158)
RITUXIMAB (3,145)
LEFLUNOMIDE (3,131)
TOCILIZUMAB (2,986)
ALENDRONATE (2,851)
TOFACITINIB (2,831)
HYDROXYCHLOROQUINE (2,717)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Osteoarthritis Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE